Literature DB >> 24878044

Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.

David Taïeb1, Henri J L M Timmers, Barry L Shulkin, Karel Pacak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24878044      PMCID： PMC4079302          DOI： 10.1210/jc.2014-1048

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.

Authors:  Sophie Gabriel; Elise M Blanchet; Frédéric Sebag; Clara C Chen; Nicolas Fakhry; Arnaud Deveze; Anne Barlier; Isabelle Morange; Karel Pacak; David Taïeb
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-06       Impact factor: 3.478

3.  Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

Authors:  Stefan Hoegerle; Egbert Nitzsche; Carsten Altehoefer; Nadir Ghanem; Tanja Manz; Ingo Brink; Martin Reincke; Ernst Moser; Hartmut P H Neumann
Journal:  Radiology       Date:  2002-02       Impact factor: 11.105

4.  Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.

Authors:  B L Shulkin; N W Thompson; B Shapiro; I R Francis; J C Sisson
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

5.  Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Graeme Eisenhofer; Kathryn S King; Jyotsna U Rao; Robert A Wesley; Karen T Adams; Karel Pacak
Journal:  J Natl Cancer Inst       Date:  2012-04-18       Impact factor: 13.506

6.  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Alexander Ling; Bastiaan Havekes; Graeme Eisenhofer; Lucia Martiniova; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

7.  Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Anna Kozupa; Clara C Chen; Jorge A Carrasquillo; Alexander Ling; Graeme Eisenhofer; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Oncol       Date:  2007-06-01       Impact factor: 44.544

8.  Scintigraphic localization of pheochromocytoma.

Authors:  J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245
  8 in total
  8 in total

1.  The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study.

Authors:  Philippe Garrigue; Aurore Bodin-Hullin; Laure Balasse; Samantha Fernandez; Wassim Essamet; Françoise Dignat-George; Karel Pacak; Benjamin Guillet; David Taïeb
Journal:  J Nucl Med       Date:  2017-06-15       Impact factor: 10.057

2.  Metabolic Subtyping of Pheochromocytoma and Paraganglioma by 18F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning.

Authors:  Anouk van Berkel; Dennis Vriens; Eric P Visser; Marcel J R Janssen; Martin Gotthardt; Ad R M M Hermus; Lioe-Fee de Geus-Oei; Henri J L M Timmers
Journal:  J Nucl Med       Date:  2018-11-09       Impact factor: 10.057

3.  18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.

Authors:  Elise M Blanchet; David Taieb; Corina Millo; Victoria Martucci; Clara C Chen; Maria Merino; Peter Herscovitch; Karel Pacak
Journal:  J Nucl Med       Date:  2015-09-10       Impact factor: 10.057

4.  Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.

Authors:  Arthur Varoquaux; Yann le Fur; Alessio Imperiale; Antony Reyre; Marion Montava; Nicolas Fakhry; Izzie-Jacques Namer; Guy Moulin; Karel Pacak; Maxime Guye; David Taïeb
Journal:  Endocr Relat Cancer       Date:  2015-06-26       Impact factor: 5.678

5.  Implications of SDHB genetic testing in patients with sporadic pheochromocytoma.

Authors:  Aurelie Maignan; Carole Guerin; Valentin Julliard; Nunzia-Cinzia Paladino; Edward Kim; Philippe Roche; Fréderic Castinetti; Wassim Essamet; Julien Mancini; Alessio Imperiale; Roderick Clifton-Bligh; Pauline Romanet; Anne Barlier; Karel Pacak; Fréderic Sebag; David Taïeb
Journal:  Langenbecks Arch Surg       Date:  2017-02-22       Impact factor: 3.445

Review 6.  Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations.

Authors:  Edward P Lin; Bennett B Chin; Lauren Fishbein; Toshio Moritani; Simone P Montoya; Shehanaz Ellika; Shawn Newlands
Journal:  Radiol Imaging Cancer       Date:  2022-05

Review 7.  Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options.

Authors:  Karren Antonio; Ma Margarita Noreen Valdez; Leilani Mercado-Asis; David Taïeb; Karel Pacak
Journal:  Gland Surg       Date:  2020-02

Review 8.  Functional Imaging of Paragangliomas with an Emphasis on Von Hippel-Lindau-Associated Disease: A Mini Review.

Authors:  Ioannis Ilias; Georgios Meristoudis
Journal:  J Kidney Cancer VHL       Date:  2017-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.